IL151141A0 - Method for classifying and treating physiologic brain imbalances using quantitative eeg - Google Patents

Method for classifying and treating physiologic brain imbalances using quantitative eeg

Info

Publication number
IL151141A0
IL151141A0 IL15114101A IL15114101A IL151141A0 IL 151141 A0 IL151141 A0 IL 151141A0 IL 15114101 A IL15114101 A IL 15114101A IL 15114101 A IL15114101 A IL 15114101A IL 151141 A0 IL151141 A0 IL 151141A0
Authority
IL
Israel
Prior art keywords
outcome measurement
multivariate
medication
measurement
classifying
Prior art date
Application number
IL15114101A
Other languages
English (en)
Original Assignee
Cns Response Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cns Response Inc filed Critical Cns Response Inc
Publication of IL151141A0 publication Critical patent/IL151141A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4833—Assessment of subject's compliance to treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
    • A61B5/0006—ECG or EEG signals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/369—Electroencephalography [EEG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/369—Electroencephalography [EEG]
    • A61B5/372—Analysis of electroencephalograms
    • A61B5/374—Detecting the frequency distribution of signals, e.g. detecting delta, theta, alpha, beta or gamma waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/369—Electroencephalography [EEG]
    • A61B5/377—Electroencephalography [EEG] using evoked responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/70—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/1104—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb induced by stimuli or drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7253—Details of waveform analysis characterised by using transforms
    • A61B5/7257—Details of waveform analysis characterised by using transforms using Fourier transforms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Psychology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Developmental Disabilities (AREA)
  • Social Psychology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Artificial Intelligence (AREA)
  • Educational Technology (AREA)
  • Fuzzy Systems (AREA)
  • Evolutionary Computation (AREA)
  • Mathematical Physics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
IL15114101A 2000-02-09 2001-02-09 Method for classifying and treating physiologic brain imbalances using quantitative eeg IL151141A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/501,149 US6622036B1 (en) 2000-02-09 2000-02-09 Method for classifying and treating physiologic brain imbalances using quantitative EEG
PCT/US2001/004148 WO2001058351A1 (en) 2000-02-09 2001-02-09 Method for classifying and treating physiologic brain imbalances using quantitative eeg

Publications (1)

Publication Number Publication Date
IL151141A0 true IL151141A0 (en) 2003-04-10

Family

ID=23992328

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15114101A IL151141A0 (en) 2000-02-09 2001-02-09 Method for classifying and treating physiologic brain imbalances using quantitative eeg
IL151141A IL151141A (en) 2000-02-09 2002-08-08 Method for classifying and treating physiologic brain imbalances using quantitative eeg

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL151141A IL151141A (en) 2000-02-09 2002-08-08 Method for classifying and treating physiologic brain imbalances using quantitative eeg

Country Status (11)

Country Link
US (4) US6622036B1 (es)
EP (4) EP2239674A1 (es)
JP (2) JP5068409B6 (es)
AT (1) ATE433162T1 (es)
AU (2) AU3679401A (es)
CA (2) CA2399482C (es)
DE (1) DE60138870D1 (es)
ES (1) ES2329650T3 (es)
IL (2) IL151141A0 (es)
MX (1) MXPA02007696A (es)
WO (1) WO2001058351A1 (es)

Families Citing this family (185)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6622036B1 (en) * 2000-02-09 2003-09-16 Cns Response Method for classifying and treating physiologic brain imbalances using quantitative EEG
US9042988B2 (en) 1998-08-05 2015-05-26 Cyberonics, Inc. Closed-loop vagus nerve stimulation
US9415222B2 (en) 1998-08-05 2016-08-16 Cyberonics, Inc. Monitoring an epilepsy disease state with a supervisory module
US7747325B2 (en) 1998-08-05 2010-06-29 Neurovista Corporation Systems and methods for monitoring a patient's neurological disease state
US8762065B2 (en) 1998-08-05 2014-06-24 Cyberonics, Inc. Closed-loop feedback-driven neuromodulation
US7209787B2 (en) 1998-08-05 2007-04-24 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US9320900B2 (en) 1998-08-05 2016-04-26 Cyberonics, Inc. Methods and systems for determining subject-specific parameters for a neuromodulation therapy
US9375573B2 (en) 1998-08-05 2016-06-28 Cyberonics, Inc. Systems and methods for monitoring a patient's neurological disease state
DE60035232T2 (de) * 1999-07-01 2008-02-14 Pharmacia & Upjohn Co. Llc, Kalamazoo (S,S)-Reboxetin zur Behandlung von chronischem Müdigkeits-Syndrom
WO2001039664A1 (en) * 1999-12-02 2001-06-07 The General Hospital Corporation Method and apparatus for measuring indices of brain activity
EP2308557A3 (en) 2000-02-04 2011-08-24 Zoll Medical Corporation Integrated resuscitation
US7177675B2 (en) * 2000-02-09 2007-02-13 Cns Response, Inc Electroencephalography based systems and methods for selecting therapies and predicting outcomes
US7034036B2 (en) * 2000-10-30 2006-04-25 Pain Therapeutics, Inc. Inhibitors of ABC drug transporters at the blood-brain barrier
CA2446382A1 (en) * 2001-05-04 2002-11-14 University Of Virginia Patent Foundation Method, apparatus, and computer program product for assessment of attentional impairments
JP2004532475A (ja) 2001-05-15 2004-10-21 サイコジェニックス・インコーポレーテッド 行動情報工学を監視するシステムおよび方法
AU2002312565A1 (en) * 2001-06-19 2003-01-02 University Of Southern California Therapeutic decisions systems and method using stochastic techniques
EP1460933B1 (en) * 2002-01-04 2008-12-17 Aspect Medical Systems, Inc. System and method of assessment of mood disorders using eeg
US8655804B2 (en) * 2002-02-07 2014-02-18 Next Stage Evolution, Llc System and method for determining a characteristic of an individual
US20050215552A1 (en) * 2002-05-17 2005-09-29 Gadde Kishore M Method for treating obesity
EP1378851A1 (de) * 2002-07-03 2004-01-07 Siemens Aktiengesellschaft Verfahren und System zur Unterstützung bei der Auswahl eines Trainingsprogramms im Rahmen einer Therapieplanung
FR2845883B1 (fr) * 2002-10-18 2005-08-05 Centre Nat Rech Scient Procede et dispositif de suivi medical ou cognitif en temps reel par l'analyse de l'activite electromagnetique cerebrale d'un individu, application du procede pour caracteriser et differencier des etats physiologiques ou pathologiques
US6827695B2 (en) 2002-10-25 2004-12-07 Revivant Corporation Method of determining depth of compressions during cardio-pulmonary resuscitation
AU2003295943A1 (en) * 2002-11-21 2004-06-18 General Hospital Corporation Apparatus and method for ascertaining and recording electrophysiological signals
US7155285B2 (en) * 2002-12-17 2006-12-26 Xiaoming Wang Apparatus for inducing energies of alpha rhythm to the human body
US20040167423A1 (en) * 2002-12-20 2004-08-26 Luana Pillon RXc graph and RXc Z-score graph methods
SI2316456T1 (sl) 2003-04-29 2017-10-30 Orexigen Therapeutics, Inc. Sestavki za vplivanje na izgubo teže, ki obsegajo opioidni antagonist in bupropion
AU2003902115A0 (en) * 2003-05-02 2003-05-22 The University Of Queensland Method of predicting functional outcome of a stroke using eeg measures
US7418290B2 (en) * 2003-05-06 2008-08-26 Aspect Medical Systems, Inc. System and method of assessment of the efficacy of treatment of neurological disorders using the electroencephalogram
US7706871B2 (en) * 2003-05-06 2010-04-27 Nellcor Puritan Bennett Llc System and method of prediction of response to neurological treatment using the electroencephalogram
US6993380B1 (en) * 2003-06-04 2006-01-31 Cleveland Medical Devices, Inc. Quantitative sleep analysis method and system
NZ527142A (en) * 2003-07-23 2006-03-31 Douglas Pharmaceuticals Ltd A stable suspension formulation
NZ527751A (en) * 2003-08-22 2006-09-29 Brainz Instr Ltd EEG seizure analysis
US7686780B2 (en) * 2003-09-26 2010-03-30 New York University System and method for correction of intracerebral chemical imbalances
US20050101889A1 (en) 2003-11-06 2005-05-12 Freeman Gary A. Using chest velocity to process physiological signals to remove chest compression artifacts
US9757045B2 (en) * 2004-01-27 2017-09-12 Universiteit Gent System and method for adaptive drug delivery
US20050171088A1 (en) * 2004-01-30 2005-08-04 Astrazeneca Ab Treatment of psychoses with dibenzothiazepine antipsychotic
EP1577673B1 (en) * 2004-03-15 2008-07-30 F. Hoffmann-La Roche Ag The use of BNP-type peptides and ANP-type peptides for assessing the risk of suffering from a cardiovascular complication as a consequence of volume overload
WO2005089431A2 (en) * 2004-03-18 2005-09-29 University Of Virginia Patent Foundation Method, apparatus, and computer program product for stochastic psycho-physiological assessment of attentional impairments
WO2005112749A1 (en) * 2004-05-12 2005-12-01 Zoll Medical Corporation Ecg rhythm advisory method
WO2006023702A2 (en) * 2004-08-20 2006-03-02 Cypress Bioscience, Inc. Method for treating sleep related breathing disorders with setiptiline
EP1827450A4 (en) * 2004-11-17 2009-04-22 Cypress Bioscience Inc METHOD FOR REDUCING THE SIDE EFFECTS OF TREATMENT WITH MIRTAZAPINE
US8214035B2 (en) * 2004-12-17 2012-07-03 Medtronic, Inc. System and method for utilizing brain state information to modulate cardiac therapy
US8112153B2 (en) 2004-12-17 2012-02-07 Medtronic, Inc. System and method for monitoring or treating nervous system disorders
US8108046B2 (en) * 2004-12-17 2012-01-31 Medtronic, Inc. System and method for using cardiac events to trigger therapy for treating nervous system disorders
US8485979B2 (en) 2004-12-17 2013-07-16 Medtronic, Inc. System and method for monitoring or treating nervous system disorders
US20070239230A1 (en) * 2004-12-17 2007-10-11 Medtronic, Inc. System and method for regulating cardiac triggered therapy to the brain
US8112148B2 (en) 2004-12-17 2012-02-07 Medtronic, Inc. System and method for monitoring cardiac signal activity in patients with nervous system disorders
US7945316B2 (en) * 2004-12-17 2011-05-17 Medtronic, Inc. System and method for monitoring or treating nervous system disorders
US8209009B2 (en) 2004-12-17 2012-06-26 Medtronic, Inc. System and method for segmenting a cardiac signal based on brain stimulation
US8108038B2 (en) * 2004-12-17 2012-01-31 Medtronic, Inc. System and method for segmenting a cardiac signal based on brain activity
US8209019B2 (en) * 2004-12-17 2012-06-26 Medtronic, Inc. System and method for utilizing brain state information to modulate cardiac therapy
US8473043B1 (en) * 2004-12-22 2013-06-25 Neuro Wave Systems Inc. Neuro-behavioral test method for screening and evaluating therapy for ADHD and system
WO2006076478A2 (en) * 2005-01-12 2006-07-20 Aspect Medical Systems, Inc. System and method for prediction of adverse events during treatment of psychological and neurological disorders
US8825166B2 (en) 2005-01-21 2014-09-02 John Sasha John Multiple-symptom medical treatment with roving-based neurostimulation
CN101155548A (zh) * 2005-03-04 2008-04-02 曼提斯库拉Ehf.公司 评估神经病症的方法和系统
US7925338B2 (en) * 2005-03-24 2011-04-12 General Electric Company Determination of the anesthetic state of a patient
FR2884702B1 (fr) * 2005-04-21 2007-07-13 Univ Victor Segalen Bordeaux 2 Dispositif pour evaluer l'aptitude physique d'un individu
US7929737B2 (en) 2005-09-29 2011-04-19 General Electric Company Method and system for automatically generating a disease severity index
US20070081700A1 (en) * 2005-09-29 2007-04-12 General Electric Company Systems, methods and apparatus for creation of a database of images from categorical indices
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
US20070156453A1 (en) * 2005-10-07 2007-07-05 Brainlab Ag Integrated treatment planning system
US7647098B2 (en) * 2005-10-31 2010-01-12 New York University System and method for prediction of cognitive decline
EP2135603B1 (en) 2005-11-22 2013-01-02 Orexigen Therapeutics, Inc. Compositions and methods for increasing insulin sensitivity
TW200803901A (en) * 2005-11-28 2008-01-16 Orexigen Therapeutics Inc Methods of treating anxiety disorders
US8311622B2 (en) 2005-12-01 2012-11-13 Neba Health LLC Systems and methods for analyzing and assessing depression and other mood disorders using electroencephalographic (EEG) measurements
US8725243B2 (en) 2005-12-28 2014-05-13 Cyberonics, Inc. Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US8868172B2 (en) 2005-12-28 2014-10-21 Cyberonics, Inc. Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
WO2007138579A2 (en) * 2006-05-25 2007-12-06 Elminda Ltd. Neuropsychological spatiotemporal pattern recognition
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
WO2007149985A2 (en) * 2006-06-21 2007-12-27 Lexicor Medical Technology, Llc Assessing dementia and dementia-type disorders
US20080027347A1 (en) * 2006-06-23 2008-01-31 Neuro Vista Corporation, A Delaware Corporation Minimally Invasive Monitoring Methods
KR101735466B1 (ko) 2006-11-09 2017-05-15 오렉시젠 세러퓨틱스 인크. 신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형
KR20150082689A (ko) 2006-11-09 2015-07-15 오렉시젠 세러퓨틱스 인크. 단위 용량 팩키지
US8295934B2 (en) 2006-11-14 2012-10-23 Neurovista Corporation Systems and methods of reducing artifact in neurological stimulation systems
US20080183097A1 (en) 2007-01-25 2008-07-31 Leyde Kent W Methods and Systems for Measuring a Subject's Susceptibility to a Seizure
US9898656B2 (en) 2007-01-25 2018-02-20 Cyberonics, Inc. Systems and methods for identifying a contra-ictal condition in a subject
WO2009069135A2 (en) * 2007-11-29 2009-06-04 Elminda Ltd. System and method for neural modeling of neurophysiological data
US8036736B2 (en) 2007-03-21 2011-10-11 Neuro Vista Corporation Implantable systems and methods for identifying a contra-ictal condition in a subject
US8000788B2 (en) 2007-04-27 2011-08-16 Medtronic, Inc. Implantable medical device for treating neurological conditions including ECG sensing
CN101801415B (zh) 2007-05-25 2015-09-23 Rb医药品有限公司 利培酮化合物的持续递送制剂
WO2008157094A1 (en) * 2007-06-13 2008-12-24 Cypress Bioscience, Inc. Improving the tolerability of mirtazapine and a second active by using them in combination
US9788744B2 (en) 2007-07-27 2017-10-17 Cyberonics, Inc. Systems for monitoring brain activity and patient advisory device
US8244341B2 (en) * 2007-08-23 2012-08-14 Tallinn University Of Technology Method and device for determining depressive disorders by measuring bioelectromagnetic signals of the brain
EP2227725A4 (en) * 2007-11-29 2013-12-18 Elminda Ltd CLINICAL APPLICATIONS OF MODELING AND ANALYSIS OF NEUROPSYCHOLOGICAL DATA MODELS
US20090171168A1 (en) 2007-12-28 2009-07-02 Leyde Kent W Systems and Method for Recording Clinical Manifestations of a Seizure
US9259591B2 (en) 2007-12-28 2016-02-16 Cyberonics, Inc. Housing for an implantable medical device
WO2009103156A1 (en) 2008-02-20 2009-08-27 Mcmaster University Expert system for determining patient treatment response
US8626264B1 (en) * 2008-04-09 2014-01-07 James T. Beran Obtaining information about brain activity
US9613184B2 (en) * 2008-04-18 2017-04-04 Medtronic, Inc. Analyzing a washout period characteristic for psychiatric disorder therapy delivery
US10493281B2 (en) * 2008-04-18 2019-12-03 Medtronic, Inc. Timing therapy evaluation trials
WO2009129480A2 (en) * 2008-04-18 2009-10-22 Medtronic, Inc. Psychiatric disorder therapy control
CA2725930A1 (en) * 2008-05-30 2009-12-30 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
US20090312663A1 (en) * 2008-06-13 2009-12-17 New York University System and Method for Neurometric Analysis
EP3586923B1 (en) 2008-07-14 2021-06-16 Arizona Board Of Regents For And On Behalf Of Arizona State University Devices for modulating cellular activity using ultrasound
US20100076334A1 (en) 2008-09-19 2010-03-25 Unither Neurosciences, Inc. Alzheimer's cognitive enabler
US20100114237A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. Mood circuit monitoring to control therapy delivery
US8849390B2 (en) 2008-12-29 2014-09-30 Cyberonics, Inc. Processing for multi-channel signals
US8588933B2 (en) 2009-01-09 2013-11-19 Cyberonics, Inc. Medical lead termination sleeve for implantable medical devices
US8786624B2 (en) 2009-06-02 2014-07-22 Cyberonics, Inc. Processing for multi-channel signals
EP2437658B1 (en) * 2009-06-03 2019-08-21 MYnd Analytics, Inc. Method for assessing the susceptibility of a human individual suffering from a psychiatric or neurological disorder to neuromodulation treatment
AU2010286595A1 (en) 2009-08-28 2012-02-23 NEBA Health, LLC. Systems and methods to identify a subgroup of ADHD at higher risk for complicating conditions
US8914115B2 (en) * 2009-12-03 2014-12-16 Medtronic, Inc. Selecting therapy cycle parameters based on monitored brain signal
US8579812B2 (en) 2009-12-15 2013-11-12 Brainscope Company, Inc. System and methods for management of disease over time
US8577451B2 (en) * 2009-12-16 2013-11-05 Brainscope Company, Inc. System and methods for neurologic monitoring and improving classification and treatment of neurologic states
US8532757B2 (en) 2009-12-16 2013-09-10 Medtronic, Inc. Stimulation electrode selection
US8538513B2 (en) 2009-12-16 2013-09-17 Medtronic, Inc. Stimulation electrode selection
CN102724878A (zh) 2010-01-11 2012-10-10 奥雷西根治疗公司 在重度抑郁症患者中提供体重减轻疗法的方法
CN102906752B (zh) 2010-01-18 2017-09-01 艾欧敏达有限公司 用于神经生理学数据的加权分析的方法和系统
US9643019B2 (en) 2010-02-12 2017-05-09 Cyberonics, Inc. Neurological monitoring and alerts
US9814885B2 (en) 2010-04-27 2017-11-14 Medtronic, Inc. Stimulation electrode selection
US8442626B2 (en) 2010-06-21 2013-05-14 Aleksandrs Zavoronkovs Systems and methods for communicating with a computer using brain activity patterns
US8565886B2 (en) 2010-11-10 2013-10-22 Medtronic, Inc. Arousal state modulation with electrical stimulation
WO2012103224A1 (en) 2011-01-25 2012-08-02 Medtronic, Inc. Target therapy delivery site selection
US8406890B2 (en) 2011-04-14 2013-03-26 Medtronic, Inc. Implantable medical devices storing graphics processing data
CN103917159B (zh) 2011-07-20 2017-02-15 艾欧敏达有限公司 用于估算脑震荡的方法和系统
WO2013059833A1 (en) 2011-10-21 2013-04-25 Neurotrek, Inc. Method and system for direct communication
CA2867866C (en) * 2012-03-26 2022-06-21 New York University Methods and kits for assessing central nervous system integrity
US20150073294A1 (en) * 2012-03-30 2015-03-12 Agency for Science, Technology Research Method for assessing the treatment of attention-deficit/hyperactivity disorder
JP6123167B2 (ja) * 2012-04-05 2017-05-10 ソニー株式会社 脳波解析装置及び脳波解析プログラム
DK3730132T3 (da) 2012-06-06 2022-08-08 Nalpropion Pharmaceuticals Llc Sammensætning til anvendelse ved en fremgangsmåde til behandling af overvægt og obesitas hos patienter med høj kardiovaskulær risiko
WO2013192582A1 (en) * 2012-06-22 2013-12-27 Neurotrek , Inc. Device and methods for noninvasive neuromodulation using targeted transcrannial electrical stimulation
CN102715903B (zh) * 2012-07-09 2014-04-16 天津市人民医院 基于定量脑电图的脑电特征提取方法
WO2014036170A1 (en) 2012-08-29 2014-03-06 Thync, Inc. Systems and devices for coupling ultrasound energy to a body
US20140081659A1 (en) 2012-09-17 2014-03-20 Depuy Orthopaedics, Inc. Systems and methods for surgical and interventional planning, support, post-operative follow-up, and functional recovery tracking
US10136830B2 (en) 2012-11-13 2018-11-27 Elminda Ltd. Neurophysiological data analysis using spatiotemporal parcellation
US20150157235A1 (en) * 2012-12-10 2015-06-11 James J. Jelen Public Health Screening For Cognitive Health Using Dry Sensor Electroencephalogram Technology
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
WO2014152110A1 (en) * 2013-03-15 2014-09-25 Simon Adam J Multi-modal pharmaco-diagnostic assessment of brian helath
CA2906652A1 (en) 2013-03-15 2014-09-18 Adam J. Simon System and signatures for the multi-modal physiological stimulation and assessment of brain health
US10610165B2 (en) 2013-06-17 2020-04-07 New York University Methods and kits for assessing neurological and ophthalmic function and localizing neurological lesions
US11096619B2 (en) * 2013-07-12 2021-08-24 Innara Health, Inc. Neural analysis and treatment system
US10561361B2 (en) * 2013-10-20 2020-02-18 Massachusetts Institute Of Technology Using correlation structure of speech dynamics to detect neurological changes
WO2015071901A2 (en) 2013-11-13 2015-05-21 Elminda Ltd. Method and system for managing pain
US10929753B1 (en) 2014-01-20 2021-02-23 Persyst Development Corporation System and method for generating a probability value for an event
CA2957384C (en) 2014-08-04 2023-06-20 New York University Methods and kits for diagnosing, assessing or quantitating drug use, drug abuse and narcosis, internuclear ophthalmoplegia, attention deficit hyperactivity disorder (adhd), chronic traumatic encephalopathy, schizophrenia spectrum disorders and alcohol consumption
WO2016029211A1 (en) * 2014-08-22 2016-02-25 The General Hospital Corporation Systems and methods for discovery and characterization of neuroactive drugs
US10702208B2 (en) 2015-03-31 2020-07-07 Cerenion Oy Apparatus and method for electroencephalographic examination
CN104720798A (zh) * 2015-04-03 2015-06-24 上海帝仪科技有限公司 基于脑电频谱特征的疲劳检测方法及系统
CN104825159B (zh) * 2015-04-23 2017-08-22 张鸣沙 脑电同频检测方法、脑电同频刺激方法与装置
CN106175799A (zh) * 2015-04-30 2016-12-07 深圳市前海览岳科技有限公司 基于脑电波评估人体情绪和疲劳状态的方法及系统
DE102015109853A1 (de) * 2015-06-19 2016-12-22 Nclogics Ag Assistenz- und Entscheidungssystem und Verfahren zur Auswertung von Elektroenzephalogrammen
CA2901477C (en) 2015-08-25 2023-07-18 Evolution Optiks Limited Vision correction system, method and graphical user interface for implementation on electronic devices having a graphical display
WO2017066001A1 (en) 2015-10-16 2017-04-20 Zoll Medical Corporaton Dual sensor electrodes for providing enhanced resuscitation feedback
US11020035B2 (en) 2016-02-01 2021-06-01 Epitel, Inc. Self-contained EEG recording system
US20170340272A1 (en) * 2016-05-27 2017-11-30 Parexel International Corporation Decision support system for cns drug development
JP2018015327A (ja) * 2016-07-28 2018-02-01 株式会社リコー 診断装置、診断方法、プログラム
WO2018026858A1 (en) 2016-08-02 2018-02-08 New York University Methods and kits for assessing neurological function and localizing neurological lesions
MX2019006670A (es) 2016-12-11 2019-12-16 Kempharm Inc Composiciones que comprenden profarmacos de metilfenidato, procedimientos para la elaboracion y uso de los mismos.
US10034645B1 (en) * 2017-04-13 2018-07-31 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for detecting complex networks in MRI image data
CN107411739A (zh) * 2017-05-31 2017-12-01 南京邮电大学 基于双树复小波的脑电信号情绪识别特征提取方法
WO2018235076A1 (en) 2017-06-21 2018-12-27 Hadasit Medical Research Services And Development Ltd. METHOD AND SYSTEM FOR PREDICTING RESPONSE TO PHARMACOLOGICAL TREATMENT FROM EEG
EP3684463A4 (en) 2017-09-19 2021-06-23 Neuroenhancement Lab, LLC NEURO-ACTIVATION PROCESS AND APPARATUS
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
WO2019133997A1 (en) 2017-12-31 2019-07-04 Neuroenhancement Lab, LLC System and method for neuroenhancement to enhance emotional response
KR102065151B1 (ko) 2018-02-22 2020-01-10 금오공과대학교 산학협력단 안정상태 시각유발 전위(ssvep)를 이용한 조울증 환자와 조현병 환자를 분류하는 방법 및 장치
CN108388343B (zh) * 2018-02-26 2022-06-24 天津智空科技有限公司 基于专注度的脑电特征反馈对vr沉浸教学管理系统
US11457855B2 (en) 2018-03-12 2022-10-04 Persyst Development Corporation Method and system for utilizing empirical null hypothesis for a biological time series
US11219416B2 (en) 2018-03-12 2022-01-11 Persyst Development Corporation Graphically displaying evoked potentials
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
WO2019241020A1 (en) * 2018-06-15 2019-12-19 Kempharm, Inc. Serdexmethylphenidate conjugates, compositions and methods of use thereof
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
CN113382683A (zh) 2018-09-14 2021-09-10 纽罗因恒思蒙特实验有限责任公司 改善睡眠的系统和方法
US20220047204A1 (en) * 2018-09-24 2022-02-17 JÓHANNSSON Magnús Methods, Computer-Readable Media and Devices for Producing an Index
US11020402B2 (en) 2018-10-15 2021-06-01 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia
US11327563B2 (en) 2018-10-22 2022-05-10 Evolution Optiks Limited Light field vision-based testing device, adjusted pixel rendering method therefor, and online vision-based testing management system and method using same
US11966507B2 (en) 2018-10-22 2024-04-23 Evolution Optiks Limited Light field vision testing device, adjusted pixel rendering method therefor, and vision testing system and method using same
US11500460B2 (en) 2018-10-22 2022-11-15 Evolution Optiks Limited Light field device, optical aberration compensation or simulation rendering
US11500461B2 (en) 2019-11-01 2022-11-15 Evolution Optiks Limited Light field vision-based testing device, system and method
US11789531B2 (en) 2019-01-28 2023-10-17 Evolution Optiks Limited Light field vision-based testing device, system and method
US11635617B2 (en) 2019-04-23 2023-04-25 Evolution Optiks Limited Digital display device comprising a complementary light field display or display portion, and vision correction system and method using same
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep
US11902498B2 (en) 2019-08-26 2024-02-13 Evolution Optiks Limited Binocular light field display, adjusted pixel rendering method therefor, and vision correction system and method using same
US11823598B2 (en) 2019-11-01 2023-11-21 Evolution Optiks Limited Light field device, variable perception pixel rendering method therefor, and variable perception system and method using same
US11487361B1 (en) 2019-11-01 2022-11-01 Evolution Optiks Limited Light field device and vision testing system using same
US20210307672A1 (en) * 2020-04-05 2021-10-07 Epitel, Inc. Eeg recording and analysis
RU2751816C1 (ru) * 2020-08-17 2021-07-19 Автономная некоммерческая организация высшего образования «Университет Иннополис» Способ классификации двигательной активности человека
CN112617859B (zh) * 2020-12-30 2022-05-13 杭州电子科技大学 一种基于平衡脑功能网络特征的平衡能力评估方法
WO2022172792A1 (ja) * 2021-02-12 2022-08-18 学校法人慶應義塾 症状判定装置及び症状判定プログラム
KR102287191B1 (ko) * 2021-03-12 2021-08-09 주식회사 아이메디신 뇌파 데이터 분석을 통한 중증인지장애 환자 분류 방법, 서버 및 컴퓨터프로그램
US20220310263A1 (en) * 2021-03-25 2022-09-29 Larry B. Gelman Treatment protocol for assessing and managing pain, based on the patient's risk of opioid misuse, abuse, and/or addiction, and method of use
WO2023239621A1 (en) * 2022-06-05 2023-12-14 Branelie Health, Inc. Healthcare system for and methods of managing brain injury or concussion
US11918368B1 (en) 2022-10-19 2024-03-05 Epitel, Inc. Systems and methods for electroencephalogram monitoring
CN116168807B (zh) * 2022-12-19 2024-03-19 广州华见智能科技有限公司 一种基于脑电波的中医医生诊疗系统

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4128641A (en) * 1975-07-31 1978-12-05 Hzi Research Center Inc. Tetracyclic psychotropic drug
US4201224A (en) 1978-12-29 1980-05-06 Roy John E Electroencephalographic method and system for the quantitative description of patient brain states
US4579125A (en) * 1984-01-23 1986-04-01 Cns, Inc. Real-time EEG spectral analyzer
US4753246A (en) * 1986-03-28 1988-06-28 The Regents Of The University Of California EEG spatial filter and method
US4794533A (en) * 1986-11-07 1988-12-27 Cns, Inc. System activity change indicator
US4776345A (en) * 1987-09-04 1988-10-11 Cns, Inc. Interactive determination of sleep stages
US4913160A (en) * 1987-09-30 1990-04-03 New York University Electroencephalographic system and method using factor structure of the evoked potentials
US5083571A (en) 1988-04-18 1992-01-28 New York University Use of brain electrophysiological quantitative data to classify and subtype an individual into diagnostic categories by discriminant and cluster analysis
US5357976A (en) 1989-10-30 1994-10-25 Genquan Feng Method of and arrangement for diagnosing brain disease
US5176145A (en) 1990-04-25 1993-01-05 Ryback Ralph S Method for diagnosing a patient to determine whether the patient suffers from limbic system dysrhythmia
US5730146A (en) 1991-08-01 1998-03-24 Itil; Turan M. Transmitting, analyzing and reporting EEG data
WO1995018565A1 (en) 1991-09-26 1995-07-13 Sam Technology, Inc. Non-invasive neurocognitive testing method and system
US5230346A (en) 1992-02-04 1993-07-27 The Regents Of The University Of California Diagnosing brain conditions by quantitative electroencephalography
CA2142906A1 (en) * 1992-08-21 1994-03-03 Peter L. Brill Method and apparatus for measuring psychotherapy outcomes
US5287859A (en) * 1992-09-25 1994-02-22 New York University Electroencephalograph instrument for mass screening
US5267570A (en) 1992-12-30 1993-12-07 Preston Myra S Method of diagnosing and treating chronic fatigue syndrome
US5445162A (en) 1993-08-27 1995-08-29 Beth Israel Hospital Association Apparatus and method for recording an electroencephalogram during magnetic resonance imaging
US6067467A (en) * 1994-02-07 2000-05-23 New York University EEG operative and post-operative patient monitoring method
JP3310498B2 (ja) 1994-09-02 2002-08-05 独立行政法人産業技術総合研究所 生体情報解析装置および生体情報解析方法
US5737539A (en) * 1994-10-28 1998-04-07 Advanced Health Med-E-Systems Corp. Prescription creation system
EP0800680A4 (en) * 1994-10-28 1998-08-12 Advanced Health Med E Systems PRESCRIPTION MANAGEMENT SYSTEM
US5632276A (en) 1995-01-27 1997-05-27 Eidelberg; David Markers for use in screening patients for nervous system dysfunction and a method and apparatus for using same
WO1997029447A2 (en) * 1996-02-09 1997-08-14 Adeza Biomedical Corporation Method for selecting medical and biochemical diagnostic tests using neural network-related applications
US5871517A (en) 1997-01-15 1999-02-16 Somatics, Inc. Convulsive therapy apparatus to stimulate and monitor the extent of therapeutic value of the treatment
CA2288990A1 (en) * 1997-04-29 1998-11-05 Kenneth Blum, Inc. Allelic polygene diagnosis of reward deficiency syndrome and treatment
CU22550A1 (es) * 1997-08-22 1999-03-31 Cnic Ct Nac Investigaciones Sistema y método para la tomografía de la corriente eléctrica primaria del cerebro y del corazón
US6622036B1 (en) * 2000-02-09 2003-09-16 Cns Response Method for classifying and treating physiologic brain imbalances using quantitative EEG
US6016449A (en) 1997-10-27 2000-01-18 Neuropace, Inc. System for treatment of neurological disorders
KR100281650B1 (ko) 1997-11-13 2001-02-15 정선종 긍정/부정 감성 상태 판별을 위한 뇌파 분석 방법
US6016444A (en) * 1997-12-10 2000-01-18 New York University Automatic control of anesthesia using quantitative EEG
US6195576B1 (en) 1998-03-09 2001-02-27 New York University Quantitative magnetoencephalogram system and method
US6463321B2 (en) 1999-08-10 2002-10-08 Thuris Corporation Method and computer program product for assessing neurological conditions and treatments using evoked response potentials
US6223074B1 (en) * 1999-08-10 2001-04-24 Thuris Corporation Method and computer program product for assessing neurological conditions and treatments using evoked response potentials
US7177675B2 (en) * 2000-02-09 2007-02-13 Cns Response, Inc Electroencephalography based systems and methods for selecting therapies and predicting outcomes
US6434419B1 (en) 2000-06-26 2002-08-13 Sam Technology, Inc. Neurocognitive ability EEG measurement method and system

Also Published As

Publication number Publication date
ATE433162T1 (de) 2009-06-15
JP5068409B6 (ja) 2019-12-11
WO2001058351A1 (en) 2001-08-16
CA2399482C (en) 2011-06-14
CA2736615A1 (en) 2001-08-16
CA2399482A1 (en) 2001-08-16
AU2001236794B2 (en) 2004-09-09
CA2736615C (en) 2013-12-10
EP2083368A1 (en) 2009-07-29
US8632750B2 (en) 2014-01-21
US8562951B2 (en) 2013-10-22
DE60138870D1 (de) 2009-07-16
MXPA02007696A (es) 2004-09-10
JP5068409B2 (ja) 2012-11-07
EP2239674A1 (en) 2010-10-13
EP1253853A4 (en) 2005-08-17
IL151141A (en) 2010-02-17
US20040059241A1 (en) 2004-03-25
JP2003521987A (ja) 2003-07-22
AU3679401A (en) 2001-08-20
EP1253853B1 (en) 2009-06-03
US20120253219A1 (en) 2012-10-04
EP1253853A1 (en) 2002-11-06
JP5259766B6 (ja) 2019-11-20
US7754190B2 (en) 2010-07-13
JP2011172942A (ja) 2011-09-08
US20100298735A1 (en) 2010-11-25
JP5259766B2 (ja) 2013-08-07
US6622036B1 (en) 2003-09-16
ES2329650T3 (es) 2009-11-30
EP2339490A1 (en) 2011-06-29

Similar Documents

Publication Publication Date Title
AU3679401A (en) Method for classifying and treating physiologic brain imbalances using quantitative eeg
Herrmann et al. Reflections on the topics: EEG frequency bands and regulation of vigilance
King et al. Optimism, coping, and long‐term recovery from coronary artery surgery in women
Zbinden et al. Anesthetic depth defined using multiple noxious stimuli during isoflurane/oxygen anesthesia. II. Hemodynamic responses.
Polich Response mode and P300 from auditory stimuli
WO2000041613A3 (en) Expert system for real-time decision support
Orentreich et al. Acne scar revision update.
Piatt Jr et al. Hydrocephalus and epilepsy: an actuarial analysis
EP0354553A3 (en) Aryl cyanoguanidines: potassium channel activators and method of making same
Krettek et al. Current status of surgical technique for unreamed nailing of tibial shaft fractures with the UTN (unreamed tibia nail)
NO904801L (no) Fremgangsmaate for fremstilling av acat-inhibitorer.
Wei et al. Development of a rule-based automatic five-sleep-stage scoring method for rats
Hanson et al. The ictal EEG as a predictive factor for outcome following corpus callosum section in adults
ATE422842T1 (de) Erfassung von signalen biologischen ursprungs
ATE308793T1 (de) Übertragungskabel für medizinische signalwerte
DE3768150D1 (de) Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie.
Marosi et al. Event-related potentials in vegetative state
Van Bemmel et al. Changes in EEG power density of non-REM sleep in depressed patients during treatment with trazodone
Johannisson et al. The alpha rhythm in the electroencephalogram: a theory based on a neurophysiological model
Fishbain Do compulsive buyers and kleptomaniacs share identical characteristics?
Schultz et al. Changes with age in EEG during anesthesia
Goodrich et al. Drama therapy with a learning disabled, personality disordered adolescent.
Ritter Corpus Callosotomy in Children
Ning et al. Bispectral analysis of the EEG in developing rats
Alghamdi et al. A Scoping Review of Protocol and Yield of Hyperventilation During Electroencephalography.